[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Crescent Biopharma Inc (CBIO)

Crescent Biopharma Inc (CBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 407,017
  • Shares Outstanding, K 27,557
  • Annual Sales, $ 10,840 K
  • Annual Income, $ -153,940 K
  • EBIT $ -186 M
  • EBITDA $ -186 M
  • 60-Month Beta 1.20
  • Price/Sales 41.78
  • Price/Cash Flow N/A
  • Price/Book 2.52

Options Overview Details

View History
  • Implied Volatility 117.52% (-29.00%)
  • Historical Volatility 71.46%
  • IV Percentile 73%
  • IV Rank 0.00%
  • IV High 146.52% on 07/29/26
  • IV Low 117.52% on 07/30/26
  • Expected Move (DTE 22) 0.00 (0.00%)
  • Put/Call Vol Ratio 999.99
  • Today's Volume 1
  • Volume Avg (30-Day) 4
  • Put/Call OI Ratio 0.57
  • Today's Open Interest 11
  • Open Int (30-Day) 6
  • Expected Range 15.19 to 15.19

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.78
  • Number of Estimates 4
  • High Estimate $-0.73
  • Low Estimate $-0.83
  • Prior Year $-4.93
  • Growth Rate Est. (year over year) +84.18%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.36 +4.60%
on 07/30/26
18.52 -18.90%
on 07/01/26
-2.98 (-16.56%)
since 06/30/26
3-Month
14.36 +4.60%
on 07/30/26
22.52 -33.30%
on 05/29/26
-7.35 (-32.86%)
since 04/30/26
52-Week
8.72 +72.25%
on 02/09/26
27.41 -45.20%
on 04/22/26
+2.42 (+19.21%)
since 07/30/25

Most Recent Stories

More News
Crescent Biopharma: Q2 Earnings Snapshot

Crescent Biopharma: Q2 Earnings Snapshot

CBIO : 15.02 (+1.69%)
Crescent Biopharma Reports Second Quarter 2026 Financial Results and Recent Business Highlights

Enrollment progressing in ASCEND Phase 1/2 global clinical trial evaluating CR-001, a PD-1 x VEGF bispecific antibody, in multiple solid tumor types in first-line and previously treated patients CR-001...

CBIO : 15.02 (+1.69%)
Crescent Biopharma Announces Grants of Inducement Awards

WALTHAM, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma , Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing...

CBIO : 15.02 (+1.69%)
Crescent Biopharma Announces Closing of Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

WALTHAM, Mass., July 16, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing...

CBIO : 15.02 (+1.69%)
Crescent Biopharma Announces Pricing of Public Offering of Ordinary Shares and Pre-Funded Warrants

WALTHAM, Mass., July 14, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing...

CBIO : 15.02 (+1.69%)
Crescent Biopharma Announces Proposed Public Offering of Ordinary Shares and Pre-Funded Warrants

WALTHAM, Mass., July 14, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing...

CBIO : 15.02 (+1.69%)
Crescent Biopharma Announces Grants of Inducement Awards

WALTHAM, Mass., June 26, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma , Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing...

CBIO : 15.02 (+1.69%)
Crescent Biopharma Announces Grants of Inducement Awards

WALTHAM, Mass., June 11, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma , Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing...

CBIO : 15.02 (+1.69%)
Crescent Biopharma to Present at June Investor Conferences

WALTHAM, Mass., June 02, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing...

CBIO : 15.02 (+1.69%)
Crescent Biopharma Announces Grants of Inducement Awards

WALTHAM, Mass., May 29, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma , Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing...

CBIO : 15.02 (+1.69%)

Business Summary

Crescent Biopharma is a biotechnology company dedicated to advancing novel precision engineered molecules targeting validated biology to advance care for patients with solid tumors. Crescent Biopharma, formerly known as GlycoMimetics Inc., is based in ROCKVILLE, Md.

See More

Key Turning Points

3rd Resistance Point 18.67
2nd Resistance Point 17.78
1st Resistance Point 16.28
Last Price 15.02
1st Support Level 13.89
2nd Support Level 13.00
3rd Support Level 11.50

See More

52-Week High 27.41
Fibonacci 61.8% 20.27
Fibonacci 50% 18.07
Fibonacci 38.2% 15.86
Last Price 15.02
52-Week Low 8.72

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.